IL37 and diabetic cardiomyopathy: Simultaneously, Huang et al. demonstrated that the administration of recombinant IL-37 or induction of endogenous IL-37 expression alleviated cardiac dysfunction and fibrosis in diabetic cardiomyopathy mice [35].